These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 3137071)

  • 1. Interpretation of nitrate plasma concentrations. Effect of cardiac output on nitroglycerin pharmacokinetics in experimental animals.
    Fung HL; Blei A; Chong S
    Eur Heart J; 1988 Jan; 9 Suppl A():39-43. PubMed ID: 3137071
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiac output is an apparent determinant of nitroglycerin pharmacokinetics in rats.
    Fung HL; Blei A; Chong S
    J Pharmacol Exp Ther; 1986 Dec; 239(3):701-5. PubMed ID: 3098960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic-hemodynamic interactions between vasopressin and nitroglycerin: comparison between intravenous and cutaneous routes of nitrate delivery.
    Blei AT; Friedman S; Gottstein J; Robertson G; Fung HL
    Hepatology; 1985; 5(2):264-70. PubMed ID: 3920134
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiovascular profile of 5 novel nitrate-esters: a comparative study with nitroglycerin in pigs with and without left ventricular dysfunction.
    van Woerkens LJ; van der Giessen WJ; Verdouw PD
    Br J Pharmacol; 1991 Sep; 104(1):7-14. PubMed ID: 1786521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and pharmacodynamics of organic nitrates.
    Fung HL
    Am J Cardiol; 1987 Nov; 60(15):4H-9H. PubMed ID: 3120565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitroglycerin pharmacokinetics after intravenous infusion in normal subjects.
    McNiff EF; Yacobi A; Young-Chang FM; Golden LH; Goldfarb A; Fung HL
    J Pharm Sci; 1981 Sep; 70(9):1054-8. PubMed ID: 6101155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetics of nitroglycerin after parenteral and oral dosing in the rat.
    Fung HL; Ogata H; Kamiya A; Maier GA
    J Pharm Sci; 1984 Jul; 73(7):873-9. PubMed ID: 6432996
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Hemodynamic effects of the administration of terlipressin alone or combined with nitroglycerin in patients with cirrhosis].
    Moreau R; Soubrane O; Hadengue A; Sogni P; Gaudin C; Kleber G; Lebrec D
    Gastroenterol Clin Biol; 1992; 16(8-9):680-6. PubMed ID: 1426824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of inhalation of nitroglycerin on hypoxic pulmonary vasoconstriction.
    Bando M; Ishii Y; Kitamura S; Ohno S
    Respiration; 1998; 65(1):63-70. PubMed ID: 9523370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Haemodynamic response to intravenous vasopressin and nitroglycerin in portal hypertension.
    Westaby D; Gimson A; Hayes PC; Williams R
    Gut; 1988 Mar; 29(3):372-7. PubMed ID: 3128465
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerance development and arterial and venous tissue-/plasma levels of glyceryl trinitrate and glyceryl dinitrate in patients treated with nitroglycerin infusion.
    Torfgård KE; Svedjeholm R; Håkansson E; Ahlner J
    Arzneimittelforschung; 1995 Sep; 45(9):963-6. PubMed ID: 7488313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hypotension and arteriovenous shunting: effects of intravenous infusion of nitroprusside, nitroglycerin and phentolamine.
    Dumont L; Lamoureux C; Lelorier J; Stanley P; Chartrand C
    Angiology; 1984 Feb; 35(2):88-96. PubMed ID: 6421204
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relationships between steady state blood concentrations and cardiac output during intravenous infusions.
    Upton RN
    Biopharm Drug Dispos; 2000 Mar; 21(2):69-76. PubMed ID: 11100908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics of nitroglycerin and long-acting nitrate esters.
    Fung HL
    Am J Med; 1983 Jun; 74(6B):13-20. PubMed ID: 6407312
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose dependent pharmacokinetics of nitroglycerin after multiple intravenous infusions in healthy volunteers.
    Noonan PK; Williams RL; Benet LZ
    J Pharmacokinet Biopharm; 1985 Apr; 13(2):143-57. PubMed ID: 3932639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haemodynamic effects of vasoactive agents following chronic state of high cardiac output in anaesthetized rats.
    Guo L; Tabrizchi R
    Eur J Pharmacol; 2008 May; 586(1-3):266-74. PubMed ID: 18367170
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of intravenous vasopressin on canine mesenteric arterial blood flow, bowel oxygen consumption, and cardiac output.
    Athanasoulis CA; Waltman AC; Simmons JT; Sheehan B; Coggins CH
    AJR Am J Roentgenol; 1978 Jun; 130(6):1033-9. PubMed ID: 418636
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of the unfavourable effects of vasopressin by nitroglycerin infusion.
    Lanza V; Demma I; Cali A; Castronovo G
    Can Anaesth Soc J; 1982 May; 29(3):243-9. PubMed ID: 6804067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clevidipine: a review of its use in the management of acute hypertension.
    Deeks ED; Keating GM; Keam SJ
    Am J Cardiovasc Drugs; 2009; 9(2):117-34. PubMed ID: 19331440
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma concentrations and haemodynamic effects of nitroglycerin during and after intravenous infusion in healthy volunteers.
    Imhof PR; Sieber A; Hodler J; Müller P; Ott B; Fankhauser P; Chu LC; Gérardin A
    Eur J Clin Pharmacol; 1982; 23(2):99-106. PubMed ID: 6814928
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.